Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €58.95 EUR
Change Today +0.464 / 0.79%
Volume 464.0
BRM On Other Exchanges
New York
Sao Paulo
As of 5:57 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles A. Bancroft

Chief Financial Officer and Executive Vice President, Bristol-Myers Squibb Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Charles A. Bancroft, also known as Charlie, has been Chief Financial Officer and an Executive Vice President of Bristol-Myers Squibb Company since April 8, 2010 and October 2011 respectively. Mr. Bancroft served as Acting Chief Financial Officer of Bristol-Myers Squibb Co. from January 1, 2010 to April 8, 2010. He served as Vice President of finance at Bristol-Myers Squibb's global biopharmaceutical business. Mr. Bancroft joined Bristol-Myers in 1984 and has since ...

Read Full Background

Corporate Headquarters*

345 Park Avenue
New York, New York 10154

United States

Phone: 212-546-4000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Drexel University
Temple University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$910,520

Stock Options*

Restricted Stock Awards$5,287,786
All Other Compensation$285,408
Exercised Options36,251
Exercised Options Value$1,100,030
Exercisable Options112,942
Exercisable Options Value$4,301,231
Total Value of Options$5,401,261
Total Number of Options149,193

Total Compensation*

Total Annual Cash Compensation$2,762,023
Total Short Term Compensation$910,520
Other Long Term Compensation$5,573,194
Total Calculated Compensation$12,054,284
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRM:GR €58.95 EUR +0.464


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at